| For: | Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol 2015; 7(3): 575-582 [PMID: 25848481 DOI: 10.4254/wjh.v7.i3.575] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/575.htm |
| Number | Citing Articles |
| 1 |
Zeinab Mokhtari, Hossein Poustchi, Tannaz Eslamparast, Azita Hekmatdoost. Egg consumption and risk of non-alcoholic fatty liver disease. World Journal of Hepatology 2017; 9(10): 503-509 doi: 10.4254/wjh.v9.i10.503
|
| 2 |
Rasha Tarif Hamza, Alaa Youssef Ahmed, Doaa Gamal Rezk, Amira Ibrahim Hamed. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease. Journal of Pediatric Endocrinology and Metabolism 2016; 29(12) doi: 10.1515/jpem-2016-0015
|
| 3 |
Minjie You, Fangfang Zheng, Tao Zhou, Yanwen Xu, Jiaying Wu, Siyu Zhuo, Xiuwei Shen, Lufeng Hu, Jiong Yu. Metabolic Profiling and Early Diagnosis of Alcoholic Fatty Liver Disease Using Support Vector Machine Model. Advanced Gut & Microbiome Research 2024; 2024(1) doi: 10.1155/2024/5744974
|
| 4 |
Davendra Kumar, Nikhil Gupta, Jalees Fatima, Ajay Kumar Mishra, Ahraz Ahmad Khan. A COMPARATIVE STUDY OF NON-ALCOHOLIC FATTY LIVER DISEASE IN RURAL AND URBAN POPULATION WITH TYPE 2 DIABETES MELLITUS. Journal of Evolution of Medical and Dental Sciences 2016; 5(45) doi: 10.14260/jemds/2016/655
|
| 5 |
Doha A. Mohamed, Karem Aly Fouda, Rasha S. Mohamed. In vitro Anticancer Activity of Quinoa and Safflower Seeds and Their Preventive Effects on Non-alcoholic Fatty Liver. Pakistan Journal of Biological Sciences 2019; 22(8) doi: 10.3923/pjbs.2019.383.392
|
| 6 |
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10) doi: 10.3390/nu9101052
|
| 7 |
Lili Ying, Yuyan Chen, Zuoquan Zhong, Yajin Wu, Lufeng Hu, Congcong Wen. Effects of long-term alcohol exposure on the pharmacokinetic profiles of ketamine and norketamine in rats. Alcohol 2021; 96 doi: 10.1016/j.alcohol.2021.01.008
|
| 8 |
Omar Ramos-Lopez, Sonia Roman, Erika Martinez-Lopez, Nora A Fierro, Karina Gonzalez-Aldaco, Alexis Jose-Abrego, Arturo Panduro. <i>CD36</i> genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. World Journal of Hepatology 2016; 8(25): 1067-1074 doi: 10.4254/wjh.v8.i25.1067
|
| 9 |
Ana Gracia, Alfredo Fernández-Quintela, Jonatan Miranda, Itziar Eseberri, Marcela González, María P. Portillo. Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?. Nutrients 2017; 9(4) doi: 10.3390/nu9040360
|
| 10 |
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry. Diabetes, Metabolic Syndrome and Obesity 2023; doi: 10.2147/DMSO.S430740
|
| 11 |
Vundrala Sumedha Reddy, S. Shiva, Srinidhi Manikantan, Seeram Ramakrishna. Pharmacology of caffeine and its effects on the human body. European Journal of Medicinal Chemistry Reports 2024; 10 doi: 10.1016/j.ejmcr.2024.100138
|
| 12 |
Katherine McGoogan, Vijay Hegde, Justin Wilburn, Felicia Cooper, Shilpa Gurnurkar, Wagner L. Prado, P. Babu Balagopal. Metabolic dysfunction-associated steatotic liver disease—a review of the cardiometabolic perspectives and treatments in children. International Journal of Obesity 2026; doi: 10.1038/s41366-026-02101-7
|
| 13 |
Rakhi Mishra, Rohit Gupta, Bela Goyal, Ajeet Singh Bhadoria, C. Vasantha Kalyani, Suresh K. Sharma, Vaidraj H. S.. Development and validation of a yoga module for adults with non-alcoholic fatty liver disease: a feasibility study. International Journal Of Community Medicine And Public Health 2025; doi: 10.18203/2394-6040.ijcmph20252238
|
| 14 |
Junling He, Weilin Mao, Juanwen Zhang, Xi Jin. Association between Serum Sialic Acid Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Annals of Nutrition and Metabolism 2015; 67(2) doi: 10.1159/000435839
|
| 15 |
Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharmaceutica 2017; 67(1) doi: 10.1515/acph-2017-0007
|
| 16 |
Wei Perng, Robyn Harte, Brandy M. Ringham, Ana Baylin, Anna Bellatorre, Ann Scherzinger, Michael I. Goran, Dana Dabelea. A Prudent dietary pattern is inversely associated with liver fat content among multi‐ethnic youth. Pediatric Obesity 2021; 16(6) doi: 10.1111/ijpo.12758
|
| 17 |
Octavia Pickett-Blakely, Laura Uwakwe, Farzana Rashid. Obesity in Women. Gastroenterology Clinics of North America 2016; 45(2) doi: 10.1016/j.gtc.2016.02.008
|
| 18 |
Xavier Pintó, Marta Fanlo-Maresma, Emili Corbella, Xavier Corbella, M Teresa Mitjavila, Juan J Moreno, Rosa Casas, Ramon Estruch, Dolores Corella, Mònica Bulló, Miguel Ruiz-Canela, Olga Castañer, J Alfredo Martinez, Emilio Ros. A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk. The Journal of Nutrition 2019; 149(11) doi: 10.1093/jn/nxz147
|
| 19 |
Carol E O’Neil, Theresa A Nicklas, Rabab Saab, Victor L Fulgoni. Relationship of added sugars intakes with physiologic parameters in adults: an analysis of national health and nutrition examination survey 2001–2012. AIMS Public Health 2020; 7(3) doi: 10.3934/publichealth.2020037
|
| 20 |
Ming Hong, Zhe Cai, Lei Song, Yongqiang Liu, Qi Wang, Xiangfei Feng, Kesara Na-Bangchang. Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/8384631
|
| 21 |
Pooja Choudhary, Bright Boamah, Siew Hon Ng, Aaron White, Lynn P. Weber, Heather L. Wilson. Solidified saturated fats coating subunit vaccines greatly extended vaccine booster release and contributed to a Th1/Th2 mixed immune response in mice. Vaccine 2023; 41(27) doi: 10.1016/j.vaccine.2023.05.023
|
| 22 |
Leixuri Aguirre, Sara Palacios-Ortega, Alfredo Fernández-Quintela, Elizabeth Hijona, Luis Bujanda, María P. Portillo. Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. Nutrients 2019; 11(5) doi: 10.3390/nu11050961
|
| 23 |
H.G. Ağalar. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; doi: 10.1016/B978-0-12-816488-4.00009-7
|
| 24 |
Rossella Tatoli, Caterina Bonfiglio, Francesco Cuccaro, Angelo Campanella, Sergio Coletta, Pasqua Letizia Pesole, Gianluigi Giannelli, Rossella Donghia. Effects of Egg Consumption on Subjects with SLD or Hypertension: A MICOL Study. Nutrients 2024; 16(3) doi: 10.3390/nu16030430
|
| 25 |
Kumi Kimura, Yuka Inaba, Hitoshi Watanabe, Toshiya Matsukawa, Michihiro Matsumoto, Hiroshi Inoue. Nicotinic alpha‐7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non‐alcoholic steatohepatitis. Journal of Diabetes Investigation 2019; 10(3) doi: 10.1111/jdi.12964
|
| 26 |
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease. 2018; doi: 10.1007/978-3-319-59180-3_10
|
| 27 |
Jennifer Miranda, Smitha Bhat. Nonalcoholic fatty liver disease in prediabetes – Predisposing and protective factors. Journal of Current Research in Scientific Medicine 2021; 7(1) doi: 10.4103/jcrsm.jcrsm_64_20
|
| 28 |
Ondrej Šeda, Monika Cahová, Irena Míková, Lucie Šedová, Helena Daňková, Marie Heczková, Miriam Brátová, Nikola Ďásková, Denisa Erhartová, Václav Čapek, Blanka Chylíková, Pavel Trunečka. Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00270
|
| 29 |
Behnam Honarvar, Kamran Bagheri Lankarani, Parisa Keshani, Tayebe Rafiee. Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran. Hepatitis Monthly 2017; 17(4) doi: 10.5812/hepatmon.44962
|
| 30 |
Esther Winters-van Eekelen, Inge Verkouter, Harry P. F. Peters, Marjan Alssema, Babette G. de Roos, Vera B. Schrauwen-Hinderling, Kay H. M. Roumans, Jan W. Schoones, Peter L. Zock, Patrick Schrauwen, Frits R. Rosendaal, Olaf M. Dekkers, Renée de Mutsert. Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition 2021; 75(4) doi: 10.1038/s41430-020-00778-1
|
| 31 |
Simona Pompili, Antonella Vetuschi, Eugenio Gaudio, Alessandra Tessitore, Roberta Capelli, Edoardo Alesse, Giovanni Latella, Roberta Sferra, Paolo Onori. Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH. Nutrition 2020; doi: 10.1016/j.nut.2020.110782
|
| 32 |
Seong-Ah Kim, Sangah Shin. Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: a prospective cohort study. Journal of Epidemiology and Community Health 2020; 74(12) doi: 10.1136/jech-2020-214568
|
| 33 |
Miey Park, Chaewon Kang, Hae-Jeung Lee. Effect of Bombyx mori on the Liver Protection of Non-Alcoholic Fatty Liver Disease Based on In Vitro and In Vivo Models. Current Issues in Molecular Biology 2021; 43(1) doi: 10.3390/cimb43010003
|
| 34 |
Gracjan Różański, Derek Pheby, Julia L. Newton, Modra Murovska, Paweł Zalewski, Joanna Słomko. Effect of Different Types of Intermittent Fasting on Biochemical and Anthropometric Parameters among Patients with Metabolic-Associated Fatty Liver Disease (MAFLD)—A Systematic Review. Nutrients 2021; 14(1) doi: 10.3390/nu14010091
|
| 35 |
Gracjan Różański, Sławomir Kujawski, Julia L. Newton, Paweł Zalewski, Joanna Słomko. Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review. Nutrients 2021; 13(8) doi: 10.3390/nu13082654
|
| 36 |
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty
Liver Disease. Current Drug Targets 2023; 24(4) doi: 10.2174/1389450124666230113150116
|
| 37 |
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver. 2018; doi: 10.1016/B978-0-12-803951-9.00017-3
|
| 38 |
Ciara H. O’Flanagan, Laura W. Bowers, Stephen D. Hursting. A weighty problem: metabolic perturbations and the obesity-cancer link. Hormone Molecular Biology and Clinical Investigation 2015; 23(2) doi: 10.1515/hmbci-2015-0022
|
| 39 |
Grzegorz Boryczka, Ewa Kosiorowska, Jakub Świętek, Kaja Głowacka, Marek Waluga. Gut microbiome in non-alcoholic fatty liver disease. Polish Journal of Public Health 2022; 132(1) doi: 10.2478/pjph-2022-0002
|
| 40 |
Carles Foguet, Silvia Marin, Vitaly A. Selivanov, Eric Fanchon, Wai-Nang Paul Lee, Joan J. Guinovart, Pedro de Atauri, Marta Cascante, Nathan E Lewis. HepatoDyn: A Dynamic Model of Hepatocyte Metabolism That Integrates 13C Isotopomer Data. PLOS Computational Biology 2016; 12(4) doi: 10.1371/journal.pcbi.1004899
|
| 41 |
QIAN XU, JI WANG, FEIFEI CHEN, KAISU LIN, MINGAO ZHU, LEI CHEN, XIUMIN ZHOU, CHONG LI, HONG ZHU. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. International Journal of Molecular Medicine 2016; 38(1) doi: 10.3892/ijmm.2016.2603
|
| 42 |
Oren Tirosh, Anna M. Giudetti. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/2548154
|
| 43 |
Kyle Salmon, Catherine C. Cohen, Leslie Lange, Dana Dabelea, Wei Perng. Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. Nutrients 2026; 18(7) doi: 10.3390/nu18071087
|
| 44 |
Charles E. Foulds, Lindsey S. Treviño, Brian York, Cheryl L. Walker. Endocrine-disrupting chemicals and fatty liver disease. Nature Reviews Endocrinology 2017; 13(8) doi: 10.1038/nrendo.2017.42
|
| 45 |
Yanxue Wang, Liang Li, Lingling Chen, Jinlei Xia, Tongli Wang, Lei Han, Liang Cao, Zhenzhong Wang, Wei Xiao, Shan Jiang. The Influence of Emodin Succinyl Ethyl Ester on Non-alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice. Biological and Pharmaceutical Bulletin 2024; 47(5) doi: 10.1248/bpb.b23-00903
|
| 46 |
Isabel Errazuriz, Simmi Dube, Michael Slama, Roberto Visentin, Sunita Nayar, Helen O’Connor, Claudio Cobelli, Swapan Kumar Das, Ananda Basu, Walter Karl Kremers, John Port, Rita Basu. Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes. The Journal of Clinical Endocrinology & Metabolism 2017; 102(5) doi: 10.1210/jc.2016-3722
|
| 47 |
Hitoshi Watanabe, Yuka Inaba, Kumi Kimura, Shun-ichiro Asahara, Yoshiaki Kido, Michihiro Matsumoto, Takayasu Motoyama, Nobuhiko Tachibana, Shuichi Kaneko, Mitsutaka Kohno, Hiroshi Inoue. Dietary Mung Bean Protein Reduces Hepatic Steatosis, Fibrosis, and Inflammation in Male Mice with Diet-Induced, Nonalcoholic Fatty Liver Disease. The Journal of Nutrition 2017; 147(1) doi: 10.3945/jn.116.231662
|
| 48 |
Riitta Ryyti, Antti Pemmari, Rainer Peltola, Mari Hämäläinen, Eeva Moilanen. Effects of Lingonberry (Vaccinium vitis-idaea L.) Supplementation on Hepatic Gene Expression in High-Fat Diet Fed Mice. Nutrients 2021; 13(11) doi: 10.3390/nu13113693
|